[{"address1": "828 Winter Street", "address2": "Suite 300", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857-524-2466", "website": "https://xiliotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 64, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rene  Russo BCPS, Pharm.D.", "age": 49, "title": "President, CEO & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 875130, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Frankenfield", "age": 42, "title": "Chief Operating Officer", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 704848, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Katarina  Luptakova M.D.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 591917, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin M. Brennan", "age": 54, "title": "Senior VP of Finance & Accounting", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Uli  Bialucha Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline  Hensley", "title": "Chief Legal Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott  Coleman Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6615, "open": 0.68, "dayLow": 0.6508, "dayHigh": 0.7154, "regularMarketPreviousClose": 0.6615, "regularMarketOpen": 0.68, "regularMarketDayLow": 0.6508, "regularMarketDayHigh": 0.7154, "payoutRatio": 0.0, "beta": -0.219, "forwardPE": -1.2224138, "volume": 142056, "regularMarketVolume": 142056, "averageVolume": 3744571, "averageVolume10days": 217410, "averageDailyVolume10Day": 217410, "bid": 0.6643, "ask": 0.743, "bidSize": 1, "askSize": 1, "marketCap": 36707552, "fiftyTwoWeekLow": 0.62, "fiftyTwoWeekHigh": 1.7, "priceToSalesTrailing12Months": 5.7861843, "fiftyDayAverage": 0.82788, "twoHundredDayAverage": 0.90905, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -11958405, "profitMargins": 0.0, "floatShares": 21998135, "sharesOutstanding": 51773700, "sharesShort": 575448, "sharesShortPriorMonth": 1810353, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0111, "heldPercentInsiders": 0.28168, "heldPercentInstitutions": 0.45719, "shortRatio": 0.3, "shortPercentOfFloat": 0.012999999, "impliedSharesOutstanding": 51773700, "bookValue": 0.385, "priceToBook": 1.8415585, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -58241000, "trailingEps": -1.09, "forwardEps": -0.58, "enterpriseToRevenue": -1.885, "enterpriseToEbitda": 0.206, "52WeekChange": -0.43730158, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 0.709, "targetHighPrice": 4.0, "targetLowPrice": 4.0, "targetMeanPrice": 4.0, "targetMedianPrice": 4.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 55291000, "totalCashPerShare": 1.068, "ebitda": -58001000, "totalDebt": 8142000, "quickRatio": 2.102, "currentRatio": 2.21, "totalRevenue": 6344000, "debtToEquity": 46.267, "revenuePerShare": 0.119, "returnOnAssets": -0.56482, "returnOnEquity": -2.14023, "grossProfits": 6344000, "freeCashflow": -16292625, "operatingCashflow": -18378000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -7.90545, "financialCurrency": "USD", "symbol": "XLO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Xilio Therapeutics, Inc.", "longName": "Xilio Therapeutics, Inc.", "exchange": "NMS", "messageBoardId": "finmb_365333564", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634909400000, "postMarketChangePercent": 1.41044, "postMarketPrice": 0.719, "postMarketChange": 0.00999999, "regularMarketChange": 0.047500014, "regularMarketDayRange": "0.6508 - 0.7154", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3744571, "fiftyTwoWeekLowChange": 0.08899999, "fiftyTwoWeekLowChangePercent": 0.14354837, "fiftyTwoWeekRange": "0.62 - 1.7", "fiftyTwoWeekHighChange": -0.99100006, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1744414295, "regularMarketTime": 1744401601, "fiftyTwoWeekHighChangePercent": -0.5829412, "fiftyTwoWeekChangePercent": -43.730156, "earningsTimestamp": 1741692658, "earningsTimestampStart": 1741692658, "earningsTimestampEnd": 1741692658, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.09, "epsForward": -0.58, "fiftyDayAverageChange": -0.11888003, "fiftyDayAverageChangePercent": -0.14359573, "twoHundredDayAverageChange": -0.20005, "twoHundredDayAverageChangePercent": -0.22006491, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-22", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 7.1806526, "regularMarketPrice": 0.709, "displayName": "Xilio Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]